Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Y Lui

Showing results (271-280 of 294) with videos related to

Pageof 30
Sort By:
Biochemical Pharmacology|November 3, 2009
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1Bo Hong, Vivian W Y Lui, Edwin P Hui, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Journal of Dental Research|December 5, 2018
Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7W Qiao, X M Lan, H X Ma, et al.
Investigational New Drugs|May 15, 2010
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaEdwin Pun Hui, Vivian W Y Lui, Cesar S C Wong, et al.
European Journal of Gastroenterology & Hepatology|May 20, 1999
Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patientsY H Huang, J C Wu, G Y Chau, et al.
The Journal of Clinical Investigation|April 2, 2016
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinomaMatthew L Hedberg, Gerald Goh, Simion I Chiosea, et al.
The Journal of Clinical Investigation|December 1, 2015
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinomaMatthew L Hedberg, Gerald Goh, Simion I Chiosea, et al.
Investigational New Drugs|September 17, 2009
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of responseBrigette B Y Ma, Vivian W Y Lui, Fan Fong Poon, et al.
Investigational New Drugs|May 9, 2012
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesBrigette B Y Ma, Vivian W Y Lui, Crystal S Cheung, et al.
Carcinogenesis|October 22, 2009
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cellsVivian W Y Lui, Daisy M S Yau, Elaine Y L Wong, et al.
Pageof 30

Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
Biochemical Pharmacology|November 3, 2009
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1Bo Hong, Vivian W Y Lui, Edwin P Hui, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Journal of Dental Research|December 5, 2018
Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7W Qiao, X M Lan, H X Ma, et al.
Investigational New Drugs|May 15, 2010
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaEdwin Pun Hui, Vivian W Y Lui, Cesar S C Wong, et al.
European Journal of Gastroenterology & Hepatology|May 20, 1999
Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patientsY H Huang, J C Wu, G Y Chau, et al.
The Journal of Clinical Investigation|April 2, 2016
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinomaMatthew L Hedberg, Gerald Goh, Simion I Chiosea, et al.
The Journal of Clinical Investigation|December 1, 2015
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinomaMatthew L Hedberg, Gerald Goh, Simion I Chiosea, et al.
Investigational New Drugs|September 17, 2009
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of responseBrigette B Y Ma, Vivian W Y Lui, Fan Fong Poon, et al.
Investigational New Drugs|May 9, 2012
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesBrigette B Y Ma, Vivian W Y Lui, Crystal S Cheung, et al.
Carcinogenesis|October 22, 2009
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cellsVivian W Y Lui, Daisy M S Yau, Elaine Y L Wong, et al.
Pageof 30